Introduction: Previous studies have shown that hyponatremia is associated with unfavorable prognosis in patients with heart failure (HF). However, only few studies aimed at the evaluation of long-term outcome in hyponatremic patients hospitalized for HF.
Objectives: The aim of this study was to assess clinical characteristics and 1-year outcome of patients hospitalized for HF with hyponatremia at hospital admission.
Patients And Methods: The study included 641 Polish participants of the HF Pilot Survey of the European Society of Cardiology. The primary endpoint was all-cause death at 1 year since index hospitalization. The secondary endpoint was all-cause death or rehospitalization for decompensated HF during a 1-year follow-up.
Results: Hyponatremia occurred in 15.8% of 641 patients. On admission, hyponatremic patients were characterized by a higher New York Heart Association class, lower blood pressure, lower body mass index, and higher creatinine and lower hemoglobin concentrations on admission. Compared with normonatremic individuals, hyponatremic patients were at a higher risk of in-hospital death (1.9% vs 9.9%, P <0.0001), death at 1 year (10.4% vs 31.7%; P <0.0001), and death or rehospitalization at 1 year (35.9% vs 56.5%; P <0.0001). In multivariate analyses, hyponatremia was predictive of both the primary (hazard ratio [HR], 3.07; 95% confidence interval [CI], 1.94-4.87; P <0.0001) and secondary endpoints (HR, 1.71; 95% CI, 1.16-2.52; P = 0.007). Hyponatremia was an independent predictor of the primary endpoint also in a subgroup of 621 patients who survived to hospital discharge (HR , 2.11; 95% CI, 1.15-3.86; P = 0.02).
Conclusions: Hyponatremia is a common finding in patients hospitalized for HF. Even in patients who survive to hospital discharge, hyponatremia on admission remains an independent predictor of death in long-term follow-up.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.20452/pamw.2701 | DOI Listing |
J Neurooncol
December 2024
UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
Purpose: BRAF and MEK inhibitors are used to treat a range of paediatric tumours including low-grade gliomas. The ubiquitous nature of the BRAF/MAPK/MEK pathway means such treatments are not without side effects such as renal tubulopathies and hyperglycaemia. This study aims to describe the endocrine dysfunction observed in a cohort of children treated with BRAF and MEK inhibitors at the largest paediatric centre in the UK utilising these treatments.
View Article and Find Full Text PDFClin Neurol Neurosurg
December 2024
Department of Pharmacy, Massachusetts General Hospital, Boston, MA, United States.
Background: Hyponatremia is common following subarachnoid hemorrhage (SAH) and is associated with vasospasm and delayed cerebral ischemia (DCI). Risk factors for post-SAH hyponatremia are poorly defined; however, selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs) are associated with hyponatremia in non-SAH populations. This study assessed whether pre-admission SSRIs/SNRIs were associated with hyponatremia after SAH.
View Article and Find Full Text PDFBest Pract Res Clin Anaesthesiol
June 2024
Department of Anesthesiology and Intensive Care Medicine, University Hospital of Tuebingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.
Adequate fluid management in the perioperative period in paediatric patients is essential for restoring and maintaining homeostasis and ensuring adequate tissue perfusion. A well-designed infusion regimen is crucial for preventing severe complications such as hyponatraemic encephalopathies. The composition of perioperative fluid solutions is now guided by an understanding of extracellular fluid physiology.
View Article and Find Full Text PDFWilderness Environ Med
December 2024
University of Arizona College of Medicine, Phoenix, AZ, USA.
ASAIO J
October 2024
From the Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Continuous venovenous hemofiltration (CVVH) is frequently performed in critically ill patients using diluted citrate for regional anticoagulation. The impact of this renal replacement strategy on plasma sodium has not been evaluated yet. Our aim was therefore to assess the period prevalence of hyponatremia (sodium <135 mmol/L) during CVVH and discuss possible underlying mechanisms.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!